By Joseph Williams on 20th December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board – December 2024

Update from the UK Pharmacy Professional Leadership Advisory Board The UK Pharmacy Professional Leadership Advisory Board met for the fourth time on 10 December 2024. Through the Board’s work, closer…

Read article
By BOPA Executive Committee on 2nd December 2024

Pharmacists’ Essential Guide to Haematology – March 2025 (UCLH Cancer Academy)

Dear All, After the hugely successful event that took place in September, UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of…

Read article
By BOPA Executive Committee on 25th November 2024

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available

Announcement: New Specialist pancreatic cancer E-Learning Resource Now Available We’re excited to announce that a new specialist e-learning resource has been added to our website! This invaluable resource, provided by…

Read article
By Joseph Williams on 6th November 2024

Hospital practices concerning the in-use storage time of (reconstituted) oncology medicines

Dear BOPA Members, The EDQM (the European Directorate for the Quality of Medicines&Healthcare of the Council of Europe) is conducting a survey following a study from national monitoring activities, which…

Read article
By Joseph Williams on 5th November 2024

New Publication by BOPA Member and AI Specialist Advisory Group (SAG) Co-Chair Pinkie Chambers

From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers New Publication by BOPA Member and AI Specialist Advisory Group (SAG)…

Read article
By BOPA Executive Committee on 4th November 2024

CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma

Dear All, I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added  form for Nivolumab with…

Read article
By BOPA IO SAG on 21st October 2024

BOPA Immunotherapy Specialist Advisory Group (SAG) – Abstract Accepted to ESMO IO 2024

A message from the BOPA Immunotherapy SAG: It brings us great pleasure to inform you that the Research & Analysis pillar of the BOPA Immunotherapy SAG has successfully submitted abstract…

Read article
By BOPA Executive Committee on 9th October 2024

Proposed BOPA Vision – We want to hear from you! Have your say today

Do you feel reflected in BOPA’s values, mission and vision? Would you add anything else?  Please contact us now – Feedback on the Proposed Vision (office.com) The Vision can be…

Read article
By BOPA Executive Committee on 17th September 2024

Introduction to Immune Checkpoint Inhibitors eLearning is LIVE for All Free and Paid BOPA Members

The winner of the #BOPA23 Oral Plenary Presentation Prize, Eleanor Meerstadt (UCLH) has collaborated with, Dr Pinkie Chambers, Dr Heather Shaw and EL Learning Design with funding from an independent medical…

Read article
By BOPA Executive Committee on 17th September 2024

RPS announces proposal to become a Royal College – BOPA and the UK PPL Board

BOPA are an ex-officio member of the UK PPL Board.  Please see the boards statement below on the RPS announcement of a proposal to become a Royal College: UK Pharmacy…

Read article
By BOPA Committee on 26th July 2024

Shereen Nabhani-Gebara (BOPA’s Vice Chair) awarded Professor at Kingston University

Dr Shereen Nabhani-Gebara is BOPA’s Vice Chair and she has been awarded Professor of Oncology at Kingston University. Shereen’s Research is dedicated to improving healthcare outcomes using technology and addressing…

Read article
By BOPA Committee on 12th June 2024

Publication update – National SACT Urology – Germ cell regimen specific consent forms

Urology – Germ cell regimen specific consent forms have been reviewed, updated and added to the CRUK website. The forms can be found at www.cruk.org/sact_consent. Please share this update within…

Read article